Valeant (VRX) Taps Goldman's (GE) Schiller as CFO
Tweet
Share
E-mail
Valeant Pharmaceuticals International, Inc. (NYSE: VRX) reports Howard B. Schiller has been named to the role of Executive Vice President and Chief Financial Officer, effective upon his commencement of employment with Valeant, which is expected to be December 1, 2011. Schiller, who recently retired from Goldman Sachs (NYS: GS) where he was the chief operating officer for the Investment Banking Division, will take over the position from Philip W. Loberg, who has been serving as Valeant's interim chief financial officer and will remain with the Company in a different role.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Boeing names Ryan Shedd as new SVP and controller
- WISeKey names Alexander Hirsch as group chief marketing officer
- Simmons Bank chief data officer Lisa Hunter to retire
Create E-mail Alert Related Categories
Management ChangesSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
